Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 51
Titolo Data di pubblicazione Autore(i) File
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial 2021 Oliva, Stefania; Hofste op Bruinink, Davine; Rihova, Lucie; D'Agostino, Mattia; Pantani, Lucia; Capra, Andrea; van der Holt, Bronno; Troia, Rossella; Petrucci, Maria Teresa; Villanova, Tania; Vsianska, Pavla; Jugooa, Romana; Brandt-Hagens, Claudia; Gilestro, Milena; Offidani, Massimo; Ribolla, Rossella; Galli, Monica; Hajek, Roman; Gay, Francesca; Cavo, Michele; Omedé, Paola; van der Velden, Vincent H J; Boccadoro, Mario; Sonneveld, Pieter
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma 2021 Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma 2021 Bruno, Benedetto; Wäsch, Ralph; Engelhardt, Monika; Gay, Francesca; Giaccone, Luisa; D'Agostino, Mattia; Rodríguez-Lobato, Luis-Gerardo; Danhof, Sophia; Gagelmann, Nico; Kröger, Nicolaus; Popat, Rakesh; Van de Donk, Niels W C J; Terpos, Evangelos; Dimopoulos, Meletios A; Sonneveld, Pieter; Einsele, Hermann; Boccadoro, Mario
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma 2021 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
MRD Assessment in Multiple Myeloma: Progress and Challenges 2021 Bertamini L.; D'Agostino M.; Gay F.
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial 2021 Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? 2020 D'Agostino M.; Mina R.; Gay F.
Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better? 2020 D'Agostino M.; Raje N.
Monoclonal antibodies to treat multiple myeloma: A dream come true 2020 D'Agostino M.; Innorcia S.; Boccadoro M.; Bringhen S.
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing 2020 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT 2020 B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia.
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma 2020 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension 2019 Bringhen S.; Milan A.; D'Agostino M.; Ferri C.; Wasch R.; Gay F.; Larocca A.; Offidani M.; Zweegman S.; Terpos E.; Goldschmidt H.; Cavo M.; Ludwig H.; Driessen C.; Auner H.W.; Caers J.; Gramatzki M.; Dimopoulos M.A.; Boccadoro M.; Einsele H.; Sonneveld P.; Engelhardt M.
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies 2019 D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F.
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino 2019 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial 2019 Bringhen, Sara; D'Agostino, Mattia; Paris, Laura; Ballanti, Stelvio; Pescosta, Norbert; Spada, Stefano; Pezzatti, Sara; Grasso, Mariella; Rota-Scalabrini, Delia; De Rosa, Luca; Pavone, Vincenzo; Gazzera, Giulia; Aquino, Sara; Poggiu, Marco; Santoro, Armando; Gentile, Massimo; Baldini, Luca; Petrucci, Maria Teresa; Tosi, Patrizia; Marasca, Roberto; Cellini, Claudia; Palumbo, Antonio; Falco, Patrizia; Hájek, Roman; Boccadoro, Mario; Larocca, Alessandra
Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo 2019 Mattia D'Agostino; Mario Boccadoro
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma 2019 D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F.
Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients 2018 Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma 2018 Oliva S.; Troia R.; D'Agostino M.; Boccadoro M.; Gay F.
Mostrati risultati da 21 a 40 di 51
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile